baricitinib

FDA approves new indication for drug to treat severe COVID-19
Beckers Hospital Review
Thu, 05/12/22 - 10:51 pm
Eli Lilly
Incyte
baricitinib
FDA
olumiant
COVID-19
Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib
Fierce Pharma
Mon, 05/10/21 - 09:25 pm
Eli Lilly
baricitinib
India
drug manufacturing
COVID-19
Lilly to seek first approval of an autoimmune drug for hair loss
BioPharma Dive
Wed, 04/21/21 - 11:26 pm
Eli Lilly
alopecia areata
baricitinib
clinical trials
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Thu, 04/8/21 - 07:40 pm
Eli Lilly
Incyte
COVID-19
baricitinib
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Wed, 03/3/21 - 10:53 am
Eli Lilly
Incyte
baricitinib
alopecia areata
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo
Sun, 11/1/20 - 01:37 pm
Eli Lilly
Incyte
baricitinib
atopic dermatitis
EADV
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Fri, 10/9/20 - 10:52 am
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Forbes
Mon, 06/15/20 - 10:54 am
Eli Lilly
COVID-19
pandemic
clinical trials
baricitinib
Lilly, Incyte get FDA breakthrough therapy status for baricitinib to treat alopecia areata
Pharmaceutical Business Review
Tue, 03/17/20 - 11:59 am
Eli Lilly
Incyte
breakthrough therapy
FDA
baricitinib
alopecia areata
Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline
Endpoints
Tue, 04/30/19 - 08:57 pm
Incyte
olumiant
baricitinib
FDA
Eli Lilly
Lilly's lupus treatment succeeds in mid-stage trial
Reuters
Thu, 06/14/18 - 09:45 am
Eli Lilly
lupus
olumiant
baricitinib
clinical trials
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning
Xconomy
Fri, 06/1/18 - 10:36 pm
Eli Lilly
Incyte
FDA
rheumatoid arthritis
olumiant
baricitinib
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Tue, 04/24/18 - 10:44 pm
Eli Lilly
earnings
baricitinib
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Xconomy
Fri, 04/20/18 - 09:30 am
Eli Lilly
baricitinib
olumiant
rheumatoid arthritis
Positive momentum for biotech Incyte
GoinPharma
Thu, 03/29/18 - 09:30 pm
Inctye
olumiant
baricitinib
rheumatoid arthritis
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
Could pain data give Lilly's baricitinib back its edge?
BioPharma Dive
Tue, 11/7/17 - 09:48 am
Eli Lilly
baricitinib
Humira
AbbVie
rheumatoid arthritis
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Xconomy
Wed, 08/30/17 - 11:12 am
Eli Lilly
rheumatoid arthritis
FDA
baricitinib
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Fierce Pharma
Wed, 07/26/17 - 10:33 pm
Eli Lilly
baricitinib
Pfizer
Xeljanz
bloodthinners

Pages